Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer

dc.contributor.author	Kim, J.
dc.contributor.author	Turan, V.
dc.contributor.author	Oktay, K.
dc.date.accessioned	2021-12-21T08:41:32Z
dc.date.available	2021-12-21T08:41:32Z
dc.date.issued	2016
dc.identifier.issn	0021972X
dc.identifier.uri	https://doi.org/10.1210/jc.2015-3878
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1453
dc.description.abstract	Context and Objective: There has been increased attention to the issue of fertility preservation (FP). We aimed to investigate the long-term safety of FP via controlled ovarian stimulation with letrozole supplementation (COSTLES) prior to breast cancer tr
dc.description.sponsorship	This work was supported in part by National Institutes of Health Grant RO1 HD053112 (to K.O.).
dc.language.iso	English
dc.publisher	Endocrine Society
dc.rights	All Open Access, Bronze, Green
dc.title	Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer
dc.type	Article
dc.relation.journal	Journal of Clinical Endocrinology and Metabolism
dc.identifier.issue	4
dc.identifier.startpage	1364
dc.identifier.endpage	1371
dc.identifier.volume	101
dc.identifier.doi	10.1210/jc.2015-3878
dc.relation.issue	4
dc.relation.volume	101